Plasma miRNAs across the Alzheimer's disease continuum: Relationship to central biomarkers is a research paper published in Alzheimer s & Dementia (2024). On theSindex it has a DataRank of 0. It has been cited 23 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
U.S. Department of Defense
Grant: W81XWH‐12‐2‐0012
National Institutes of Health
Grant: U01 AG024904
National Institutes of Health
Grant: R01 LM012535
National Institutes of Health
Grant: R03 AG063250
National Institutes of Health
Grant: R01 AG19771
National Institutes of Health
Grant: P30 AG10133
National Institutes of Health
Grant: P30 AG072976
National Institutes of Health
Grant: R01 AG057739
National Institutes of Health
Grant: R01 LM013463
National Institutes of Health
Grant: R01 AG068193
National Institutes of Health
Grant: T32 AG071444
National Institutes of Health
Grant: U01 AG068057
National Institutes of Health
Grant: U01 AG072177
National Institutes of Health
Grant: U19 AG074879
National Institutes of Health
Grant: RF1AG078299
National Institutes of Health
Grant: U19 AG024904
National Institutes of Health
Grant: P30 AG010133
National Institutes of Health
Grant: R01 AG019771
National Institutes of Health
Grant: RF1 AG057768
National Institutes of Health
Grant: P30 AG013846
National Institutes of Health
Grant: RF1 AG072654
National Institutes of Health
Grant: U01AG068221
National Institutes of Health
Grant: U01 AG058589
National Institutes of Health
Grant: R01DK122503
National Institute of General Medical Sciences
Grant: P50GM115318
National Institute of General Medical Sciences
Grant: UL1 TR001108
National Institute of General Medical Sciences
Grant: K01 AG049050
National Institute of General Medical Sciences
Grant: R01 AG061788
Deutsche Forschungsgemeinschaft
Grant: 1738
Deutsche Forschungsgemeinschaft
Grant: SFB1286
Deutsche Forschungsgemeinschaft
Grant: GRK2824
National Institutes of Health
Grant: 3R01DK122503-02S1
Integrative Approaches to Identifying Function and Clinical Significance of Adiposity Susceptibility Genes
Deutsche Forschungsgemeinschaft
Grant: unidentified
unidentified
National Institutes of Health
Grant: 1U01AG068057-01
Ultrascale Machine Learning to Empower Discovery in Alzheimers Disease Biobanks
National Institutes of Health
Grant: 5R01LM013463-03
Informatics Algorithms for Genomic Analysis of Brain Imaging Data
National Institutes of Health
Grant: 1R01LM012535-01
Integrating Neuroimaging, Multi-omics, and Clinical Data in Complex Disease
National Institutes of Health
Grant: 1R03AG063250-01
Integrative analysis of alternative splicing in Alzheimer's disease
National Institutes of Health
Grant: 1RF1AG072654-01
Precision Brain Health Monitoring for Alzheimer's Disease Risk Detection in the Framingham Study
National Institutes of Health
Grant: 1U01AG024904-01
Alzheimers Disease Neuroimaging Initiative
National Institutes of Health
Grant: 1RF1AG057768-01A1
Age-Associated Lipidomic Changes in Alzheimer's Disease
National Institutes of Health
Grant: 3UL1TR001108-02S1
Indiana Clinical and Translational Sciences Institute
National Institutes of Health
Grant: 5K01AG049050-02
Sensory and Perceptual Measures as Biomarkers of Alzheimer's Disease Pathology
National Institutes of Health
Grant: 7RF1AG078299-02
MicroRNAs as Diagnostic and Prognostic Biomarker of Alzheimer's Disease
National Institutes of Health
Grant: 5P50GM115318-03
Pharmacogenomics of Statin Therapy
National Institutes of Health
Grant: 5R01AG061788-02
Multi-Domain Sensory Measures as Biomarkers of Alzheimer's Disease in Preclinical and Prodromal Stages
National Institutes of Health
Grant: 5U01AG072177-02
KBASE2: Korean Brain Aging Study, Longitudinal Endophenotypes and Systems Biology
National Institutes of Health
Grant: 5U01AG068221-03
Assessing Alzheimer disease risk and heterogeneity using multimodal machine learning approaches
National Institutes of Health
Grant: 5R01AG068193-03
Cognitive Aging, Alzheimers disease, and Cancer-related Cognitive Decline
National Institutes of Health
Grant: 5P30AG072976-02
Indiana Alzheimer's Disease Research Center
National Institutes of Health
Grant: 2R01AG019771-06
Memory Circuitry in MCI and Early Alzheimers Disease
National Institutes of Health
Grant: 5U01AG058589-02
Therapeutic target discovery in ADSP data via comprehensive whole-genome analysis incorporating ethnic diversity and systems approaches
National Institutes of Health
Grant: 5R01AG057739-04
Leveraging Neuroimaging Biomarkers to Understand the Role of Social Networks in Alzheimer's Disease
National Institutes of Health
Grant: 3P30AG013846-23S1
Boston University Alzheimer's Disease Center
National Institutes of Health
Grant: 5P30AG010133-08
CORE-- EDUCATION AND INFORMATION TRANSFER
National Institutes of Health
Grant: 5T32AG071444-03
Training Grant on Alzheimer's Disease and ADRD at Indiana University
NIA NIH HHS
Grant: R01 AG084624
Germany's Excellence Strategy
Grant: EXC 2067/1 390729940
GoBIO project miRassay
Grant: 16LW0055
The EU Joint Programme- Neurodegenerative Diseases (JPND)
Grant: EPI-3E
Department of Defense
Grant: W81XWH-12-2-0012
IU Health-IU School of Medicine Strategic Neuroscience Research Initiative
EuroImmun
Biogen
Alzheimer's Disease Neuroimaging Initiative
Alzheimer's Drug Discovery Foundation
Servier
Lumosity
Bristol-Myers Squibb Company
Piramal Imaging
Takeda Pharmaceutical Company
Alzheimer's Association
Genentech, Inc.
ERA-NET Neuron project
Araclon Biotech
Meso Scale Diagnostics, LLC
Novartis Pharmaceuticals Corporation
CereSpir, Inc.
BioClinica, Inc.
GE Healthcare
Indiana Clinical and Translational Science Institute
AbbVie
German Federal Ministry of Science and Education
Transition Therapeutics
German Federal Ministry of 1 Science and Education
Cogstate
NIBIB NIH HHS
Johnson & Johnson Pharmaceutical Research & Development LLC
F. Hoffmann-La Roche Ltd
Pfizer Inc.
Elan Pharmaceuticals, Inc.
Eli Lilly and Company
IXICO Ltd.
NeuroRx Research
Merck & Co., Inc.
Janssen Alzheimer Immunotherapy Research & Development, LLC
Neurotrack Technologies
Fujirebio
Lundbeck
Eisai Inc.
Fields of Study
MeSH Terms
Keywords